1
|
Pten is necessary for the quiescence and maintenance of adult muscle stem cells. Nat Commun 2017; 8:14328. [PMID: 28094257 PMCID: PMC5247606 DOI: 10.1038/ncomms14328] [Citation(s) in RCA: 89] [Impact Index Per Article: 11.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/12/2016] [Accepted: 12/16/2016] [Indexed: 02/06/2023] Open
Abstract
Satellite cells (SCs) are myogenic stem cells required for regeneration of adult skeletal muscles. A proper balance among quiescence, activation and differentiation is essential for long-term maintenance of SCs and their regenerative function. Here we show a function of Pten (phosphatase and tensin homologue) in quiescent SCs. Deletion of Pten in quiescent SCs leads to their spontaneous activation and premature differentiation without proliferation, resulting in depletion of SC pool and regenerative failure. However, prior to depletion, Pten-null activated SCs can transiently proliferate upon injury and regenerate injured muscles, but continually decline during regeneration, suggesting an inability to return to quiescence. Mechanistically, Pten deletion increases Akt phosphorylation, which induces cytoplasmic translocation of FoxO1 and suppression of Notch signalling. Accordingly, constitutive activation of Notch1 prevents SC depletion despite Pten deletion. Our findings delineate a critical function of Pten in maintaining SC quiescence and reveal an interaction between Pten and Notch signalling. Pten is known to regulate haematopoietic stem cell functions. Here the authors show that Pten alteration of Notch signalling has stage-specific muscle regenerative functions in muscle stem cells by preventing premature differentiation of quiescent cells and enhancing the self-renewal of activated cells.
Collapse
|
2
|
Tartey S, Matsushita K, Vandenbon A, Ori D, Imamura T, Mino T, Standley DM, Hoffmann JA, Reichhart JM, Akira S, Takeuchi O. Akirin2 is critical for inducing inflammatory genes by bridging IκB-ζ and the SWI/SNF complex. EMBO J 2014; 33:2332-48. [PMID: 25107474 DOI: 10.15252/embj.201488447] [Citation(s) in RCA: 75] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/08/2023] Open
Abstract
Transcription of inflammatory genes in innate immune cells is coordinately regulated by transcription factors, including NF-κB, and chromatin modifiers. However, it remains unclear how microbial sensing initiates chromatin remodeling. Here, we show that Akirin2, an evolutionarily conserved nuclear protein, bridges NF-κB and the chromatin remodeling SWI/SNF complex by interacting with BRG1-Associated Factor 60 (BAF60) proteins as well as IκB-ζ, which forms a complex with the NF-κB p50 subunit. These interactions are essential for Toll-like receptor-, RIG-I-, and Listeria-mediated expression of proinflammatory genes including Il6 and Il12b in macrophages. Consistently, effective clearance of Listeria infection required Akirin2. Furthermore, Akirin2 and IκB-ζ recruitment to the Il6 promoter depend upon the presence of IκB-ζ and Akirin2, respectively, for regulation of chromatin remodeling. BAF60 proteins were also essential for the induction of Il6 in response to LPS stimulation. Collectively, the IκB-ζ-Akirin2-BAF60 complex physically links the NF-κB and SWI/SNF complexes in innate immune cell activation. By recruiting SWI/SNF chromatin remodellers to IκB-ζ, transcriptional coactivator for NF-κB, the conserved nuclear protein Akirin2 stimulates pro-inflammatory gene promoters in mouse macrophages during innate immune responses to viral or bacterial infection.
Collapse
Affiliation(s)
- Sarang Tartey
- Laboratory of Infection and Prevention Institute for Virus Research Kyoto University, Sakyo-ku Kyoto, Japan CREST JST, Sakyo-ku Kyoto, Japan Laboratory of Host Defense WPI Immunology Frontier Research Center (IFReC), Osaka University Suita, Osaka, Japan Research Institute for Microbial Diseases Osaka University, Suita Osaka, Japan
| | - Kazufumi Matsushita
- Laboratory of Allergic Diseases Institute for Advanced Medical Sciences Hyogo College of Medicine, Suita Osaka, Japan
| | - Alexis Vandenbon
- Laboratory of Systems Immunology WPI Immunology Frontier Research Center (IFReC), Nishinomiya Hyogo, Japan
| | - Daisuke Ori
- Laboratory of Infection and Prevention Institute for Virus Research Kyoto University, Sakyo-ku Kyoto, Japan CREST JST, Sakyo-ku Kyoto, Japan
| | - Tomoko Imamura
- Laboratory of Infection and Prevention Institute for Virus Research Kyoto University, Sakyo-ku Kyoto, Japan CREST JST, Sakyo-ku Kyoto, Japan
| | - Takashi Mino
- Laboratory of Infection and Prevention Institute for Virus Research Kyoto University, Sakyo-ku Kyoto, Japan CREST JST, Sakyo-ku Kyoto, Japan
| | - Daron M Standley
- Laboratory of Systems Immunology WPI Immunology Frontier Research Center (IFReC), Nishinomiya Hyogo, Japan
| | | | | | - Shizuo Akira
- Laboratory of Host Defense WPI Immunology Frontier Research Center (IFReC), Osaka University Suita, Osaka, Japan Research Institute for Microbial Diseases Osaka University, Suita Osaka, Japan
| | - Osamu Takeuchi
- Laboratory of Infection and Prevention Institute for Virus Research Kyoto University, Sakyo-ku Kyoto, Japan CREST JST, Sakyo-ku Kyoto, Japan Laboratory of Host Defense WPI Immunology Frontier Research Center (IFReC), Osaka University Suita, Osaka, Japan
| |
Collapse
|
3
|
Abstract
Every known SWI/SNF chromatin-remodeling complex incorporates an ARID DNA binding domain-containing subunit. Despite being a ubiquitous component of the complex, physiological roles for this domain remain undefined. Here, we show that disruption of ARID1a-DNA binding in mice results in embryonic lethality, with mutant embryos manifesting prominent defects in the heart and extraembryonic vasculature. The DNA binding-defective mutant ARID1a subunit is stably expressed and capable of assembling into a SWI/SNF complex with core catalytic properties, but nucleosome substrate binding and promoter occupancy by ARID1a-containing SWI/SNF complexes (BAF-A) are impaired. Depletion of ARID domain-dependent, BAF-A associations at THROMBOSPONDIN 1 (THBS1) led to the concomitant upregulation of this SWI/SNF target gene. Using a THBS1 promoter-reporter gene, we further show that BAF-A directly regulates THBS1 promoter activity in an ARID domain-dependent manner. Our data not only demonstrate that ARID1a-DNA interactions are physiologically relevant in higher eukaryotes but also indicate that these interactions facilitate SWI/SNF binding to target sites in vivo. These findings support the model wherein cooperative interactions among intrinsic subunit-chromatin interaction domains and sequence-specific transcription factors drive SWI/SNF recruitment.
Collapse
|
4
|
Potts RC, Zhang P, Wurster AL, Precht P, Mughal MR, Wood WH, Zhang Y, Becker KG, Mattson MP, Pazin MJ. CHD5, a brain-specific paralog of Mi2 chromatin remodeling enzymes, regulates expression of neuronal genes. PLoS One 2011; 6:e24515. [PMID: 21931736 PMCID: PMC3172237 DOI: 10.1371/journal.pone.0024515] [Citation(s) in RCA: 73] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/18/2011] [Accepted: 08/12/2011] [Indexed: 11/19/2022] Open
Abstract
CHD5 is frequently deleted in neuroblastoma and is a tumor suppressor gene. However, little is known about the role of CHD5 other than it is homologous to chromatin remodeling ATPases. We found CHD5 mRNA was restricted to the brain; by contrast, most remodeling ATPases were broadly expressed. CHD5 protein isolated from mouse brain was associated with HDAC2, p66ß, MTA3 and RbAp46 in a megadalton complex. CHD5 protein was detected in several rat brain regions and appeared to be enriched in neurons. CHD5 protein was predominantly nuclear in primary rat neurons and brain sections. Microarray analysis revealed genes that were upregulated and downregulated when CHD5 was depleted from primary neurons. CHD5 depletion altered expression of neuronal genes, transcription factors, and brain-specific subunits of the SWI/SNF remodeling enzyme. Expression of gene sets linked to aging and Alzheimer's disease were strongly altered by CHD5 depletion from primary neurons. Chromatin immunoprecipitation revealed CHD5 bound to these genes, suggesting the regulation was direct. Together, these results indicate that CHD5 protein is found in a NuRD-like multi-protein complex. CHD5 expression is restricted to the brain, unlike the closely related family members CHD3 and CHD4. CHD5 regulates expression of neuronal genes, cell cycle genes and remodeling genes. CHD5 is linked to regulation of genes implicated in aging and Alzheimer's disease.
Collapse
Affiliation(s)
- Rebecca Casaday Potts
- Laboratory of Molecular Biology and Immunology, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Peisu Zhang
- Laboratory of Neuroscience, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Andrea L. Wurster
- Laboratory of Molecular Biology and Immunology, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Patricia Precht
- Laboratory of Molecular Biology and Immunology, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Mohamed R. Mughal
- Laboratory of Neuroscience, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - William H. Wood
- Research Resources Branch, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Yonqing Zhang
- Research Resources Branch, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Kevin G. Becker
- Research Resources Branch, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Mark P. Mattson
- Laboratory of Neuroscience, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
| | - Michael J. Pazin
- Laboratory of Molecular Biology and Immunology, National Institute on Aging Intramural Research Program, National Institutes of Health, Baltimore, Maryland, United States of America
- * E-mail:
| |
Collapse
|
5
|
Guo R, Xu D, Wang W. Identification and analysis of new proteins involved in the DNA damage response network of Fanconi anemia and Bloom syndrome. Methods 2009; 48:72-9. [PMID: 19245838 PMCID: PMC2693241 DOI: 10.1016/j.ymeth.2009.02.011] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2008] [Accepted: 02/15/2009] [Indexed: 12/25/2022] Open
Abstract
The use of co-immunoprecipitation (co-IP) to purify multi-protein complexes has contributed greatly to our understanding of the DNA damage response network associated with Fanconi anemia (FA), Bloom syndrome (BS) and breast cancer. Four new FA genes and two new protein partners for the Bloom syndrome gene product have been identified by co-IP. Here, we discuss our experience in using co-IP and other techniques to isolate and characterize new FA and BS-related proteins.
Collapse
Affiliation(s)
- Rong Guo
- Laboratory of Genetics, National Institute on Aging, National Institutes of Health, NIH Biomedical Research Center Room 10B113, 251 Bayview Boulevard, Baltimore, Maryland 21224
| | - Dongyi Xu
- Laboratory of Genetics, National Institute on Aging, National Institutes of Health, NIH Biomedical Research Center Room 10B113, 251 Bayview Boulevard, Baltimore, Maryland 21224
| | - Weidong Wang
- Laboratory of Genetics, National Institute on Aging, National Institutes of Health, NIH Biomedical Research Center Room 10B113, 251 Bayview Boulevard, Baltimore, Maryland 21224
| |
Collapse
|
6
|
Wan M, Zhang J, Lai D, Jani A, Prestone-Hurlburt P, Ramachandran A, Schnitzler GR, Chi T. Molecular basis of CD4 repression by the Swi/Snf-like BAF chromatin remodeling complex. Eur J Immunol 2009; 39:580-8. [PMID: 19180471 PMCID: PMC2774848 DOI: 10.1002/eji.200838909] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Abstract
The Brg1/Brm-associated factor (BAF) chromatin remodeling complex directly binds the CD4 silencer and is essential for CD4 repression during T-cell development, because deletion of the ATPase subunit Brg1 or a dominant negative mutant of BAF57 each impairs CD4 repression in early thymocytes. Paradoxically, BAF57 is dispensable for remodeling nucleosomes in vitro or for binding of the BAF complex to the CD4 silencer in vivo. Thus, it is unclear whether BAF57-dependent CD4 repression involves chromatin remodeling and, if so, how the remodeling translates into CD4 repression. Here we show that nucleosomes at the CD4 silencer occupy multiple translational frames. BAF57 dominant negative mutant does not alter these frames, but reduces the accessibility of the entire silencer without affecting the flanking regions, concomitant with localized accumulation of linker histone H1 and eviction of Runx1, a key repressor of CD4 transcription that directly binds the CD4 silencer. Our data indicate that precise nucleosome positioning is not critical for the CD4 silencer function and that BAF57 participates in remodeling H1-containing chromatin at the CD4 silencer, which enables Runx1 to access the silencer and repress CD4. In addition to BAF57, multiple other subunits in the BAF complex are also dispensable for chromatin remodelling in vitro. Our data suggest that these subunits could also help remodel chromatin at a step after the recruitment of the BAF complex to target genes.
Collapse
Affiliation(s)
- Mimi Wan
- Department of Immunobiology, Yale University Medical School, New Haven, Connecticut, USA
| | - Jianmin Zhang
- Department of Immunobiology, Yale University Medical School, New Haven, Connecticut, USA
| | - Dazhi Lai
- Department of Immunobiology, Yale University Medical School, New Haven, Connecticut, USA
| | - Anant Jani
- Department of Immunobiology, Yale University Medical School, New Haven, Connecticut, USA
| | | | - Aruna Ramachandran
- Department of Biochemistry, Tufts University Sackler School of Graduate Biomedical Sciences, Boston, Massachusetts, USA
| | - Gavin R. Schnitzler
- Department of Biochemistry, Tufts University Sackler School of Graduate Biomedical Sciences, Boston, Massachusetts, USA
| | - Tian Chi
- Department of Immunobiology, Yale University Medical School, New Haven, Connecticut, USA
| |
Collapse
|
7
|
Induction of TLR4-target genes entails calcium/calmodulin-dependent regulation of chromatin remodeling. Proc Natl Acad Sci U S A 2009; 106:1169-74. [PMID: 19164553 DOI: 10.1073/pnas.0811274106] [Citation(s) in RCA: 42] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023] Open
Abstract
Upon toll-like receptor 4 (TLR4) signaling in macrophages, the mammalian Swi/Snf-like BAF chromatin remodeling complex is recruited to many TLR4 target genes where it remodels their chromatin to promote transcription. Here, we show that, surprisingly, recruitment is not sufficient for chromatin remodeling; a second event, dependent on calcium/calmodulin (CaM), is additionally required. Calcium/CaM directly binds the HMG domain of the BAF57 subunit within the BAF complex. Calcium/CaM antagonists, including a CaM-binding peptide derived from BAF57, abolish BAF-dependent remodeling and gene expression without compromising BAF recruitment. BAF57 RNAi and BAF57 dominant negative mutants defective in CaM binding similarly impair the induction of BAF target genes. Our data implicate calcium/CaM in TLR4 signaling, and reveal a previously undescribed, recruitment-independent mode of regulation of the BAF complex that is probably achieved through a direct CaM-BAF interaction.
Collapse
|
8
|
Yan Z, Wang Z, Sharova L, Sharov AA, Ling C, Piao Y, Aiba K, Matoba R, Wang W, Ko MS. BAF250B-associated SWI/SNF chromatin-remodeling complex is required to maintain undifferentiated mouse embryonic stem cells. Stem Cells 2008; 26:1155-65. [PMID: 18323406 PMCID: PMC2409195 DOI: 10.1634/stemcells.2007-0846] [Citation(s) in RCA: 138] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Whether SWI/SNF chromatin remodeling complexes play roles in embryonic stem (ES) cells remains unknown. Here we show that SWI/SNF complexes are present in mouse ES cells, and their composition is dynamically regulated upon induction of ES cell differentiation. For example, the SWI/SNF purified from undifferentiated ES cells contains a high level of BAF155 and a low level of BAF170 (both of which are homologs of yeast SWI3 protein), whereas that from differentiated cells contains nearly equal amounts of both. Moreover, the levels of BAF250A and BAF250B decrease during the differentiation of ES cells, whereas that of BRM increases. The altered expression of SWI/SNF components hinted that these complexes could play roles in ES cell maintenance or differentiation. We therefore generated ES cells with biallelic inactivation of BAF250B and found that these cells display a reduced proliferation rate and an abnormal cell cycle. Importantly, these cells are deficient in the self-renewal capacity of undifferentiated ES cells and exhibit certain phenotypes of differentiated cells, including reduced expression of several pluripotency-related genes and increased expression of some differentiation-related genes. These data suggest that the BAF250B-associated SWI/SNF is essential for mouse ES cells to maintain their normal proliferation and pluripotency. The work presented here underscores the importance of SWI/SNF chromatin remodeling complexes in pluripotent stem cells.
Collapse
Affiliation(s)
- Zhijiang Yan
- Genome Instability and Chromatin-Remodeling Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| | - Zhong Wang
- Cardiovascular Research Center, Massachusetts General Hospital, Richard B. Simches Research Center, Harvard Medical School, Boston, MA 02114
| | - Lioudmila Sharova
- Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| | - Alexei A. Sharov
- Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| | - Chen Ling
- Genome Instability and Chromatin-Remodeling Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| | - Yulan Piao
- Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| | - Kazuhiro Aiba
- Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| | - Ryo Matoba
- Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| | - Weidong Wang
- Genome Instability and Chromatin-Remodeling Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| | - Minoru S.H. Ko
- Developmental Genomics and Aging Section, Laboratory of Genetics, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224
| |
Collapse
|
9
|
Nucleoprotein structure of the CD4 locus: implications for the mechanisms underlying CD4 regulation during T cell development. Proc Natl Acad Sci U S A 2008; 105:3873-8. [PMID: 18322012 DOI: 10.1073/pnas.0800810105] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022] Open
Abstract
The CD4 gene is regulated in a stage-specific manner during T cell development, being repressed in CD4(-)CD8(-) double-negative (DN) and CD8 cells, but expressed in CD4(+)CD8(+) double-positive (DP) and CD4 cells. Furthermore, the expression/repression pattern is reversible in developing (DN and DP) thymocytes, but irreversible in mature (CD4 and CD8) T cells. Here, we explored the molecular mechanisms underlying this complex mode of regulation by examining the nucleoprotein structure of the CD4 locus throughout T cell development and in DN cells lacking the CD4 silencer. In DN cells, the CD4 enhancer is preloaded with multiple transcription activators, but p300 recruitment is impaired by the silencer that is associated with the repressor Runx1. DP cells achieve high-level CD4 expression via a combination of CD4 derepression and true activation, but Runx1 remains bound to the silencer that retains an open chromatin configuration. In CD4 cells, Runx1 dissociates from the silencer that has become less accessible, and CD4 transcription appears to be achieved via a mechanism distinct from that operating in DP cells. In CD8 cells, the CD4 promoter becomes incorporated into heterochromatin-like structure. Our data shed light on the molecular basis of CD4 regulation and provide a conceptual framework for understanding how the same regulatory elements can mediate both reversible and irreversible CD4 regulation.
Collapse
|
10
|
Kitamura T, Kitamura YI, Funahashi Y, Shawber CJ, Castrillon DH, Kollipara R, DePinho RA, Kitajewski J, Accili D. A Foxo/Notch pathway controls myogenic differentiation and fiber type specification. J Clin Invest 2007; 117:2477-85. [PMID: 17717603 PMCID: PMC1950461 DOI: 10.1172/jci32054] [Citation(s) in RCA: 236] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/07/2007] [Accepted: 06/06/2007] [Indexed: 01/21/2023] Open
Abstract
Forkhead box O (Foxo) transcription factors govern metabolism and cellular differentiation. Unlike Foxo-dependent metabolic pathways and target genes, the mechanisms by which these proteins regulate differentiation have not been explored. Activation of Notch signaling mimics the effects of Foxo gain of function on cellular differentiation. Using muscle differentiation as a model system, we show that Foxo physically and functionally interacts with Notch by promoting corepressor clearance from the Notch effector Csl, leading to activation of Notch target genes. Inhibition of myoblast differentiation by constitutively active Foxo1 is partly rescued by inhibition of Notch signaling while Foxo1 loss of function precludes Notch inhibition of myogenesis and increases myogenic determination gene (MyoD) expression. Accordingly, conditional Foxo1 ablation in skeletal muscle results in increased formation of MyoD-containing (fast-twitch) muscle fibers and altered fiber type distribution at the expense of myogenin-containing (slow-twitch) fibers. Notch/Foxo1 cooperation may integrate environmental cues through Notch with metabolic cues through Foxo1 to regulate progenitor cell maintenance and differentiation.
Collapse
Affiliation(s)
- Tadahiro Kitamura
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| | - Yukari Ido Kitamura
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| | - Yasuhiro Funahashi
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| | - Carrie J. Shawber
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| | - Diego H. Castrillon
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| | - Ramya Kollipara
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| | - Ronald A. DePinho
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| | - Jan Kitajewski
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| | - Domenico Accili
- Department of Medicine, Columbia University College of Physicians and
Surgeons, New York, New York, USA. Metabolic Signal Research Center,
Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Japan.
Department of Pathology and Obstetrics/Gynecology, Columbia
University College of Physicians and Surgeons, New York, New York, USA.
Department of Pathology, University of Texas Southwestern Medical
Center, Dallas, Texas, USA. Center for Applied Cancer Science,
Departments of Medical Oncology, Medicine, and Genetics, and Belfer Institute for
Innovative Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston,
Massachusetts, USA
| |
Collapse
|